Trulieve Cannabis (TRLV) Cost of Revenue (2020 - 2026)

Trulieve Cannabis has reported Cost of Revenue for 7 years, with the latest figure at $108.7 million in Q2 2026.

• On a quarterly basis, Cost of Revenue fell 8.81% year-over-year to $108.7 million in Q2 2026; TTM through Jun 2026 was $461.6 million, a 0.61% increase from a year earlier, with the FY2025 full-year figure at $470.0 million, changed 0.16% from the prior year.
• Cost of Revenue was $108.7 million for Q2 2026 at Trulieve Cannabis, down from $116.7 million in the prior quarter.
• The five-year high for Cost of Revenue was $141.4 million in Q4 2022, with the low at $108.7 million in Q2 2026.
• Average Cost of Revenue over 5 years is $124.6 million, with a median of $122.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue surged 134.45% in 2022, then retreated 16.07% in 2024.
• Over 5 years, Cost of Revenue stood at $141.4 million in 2022, then dropped by 5.83% to $133.1 million in 2023, then dropped by 14.27% to $114.1 million in 2024, then rose by 3.38% to $118.0 million in 2025, then slipped by 7.9% to $108.7 million in 2026.
• The last three Cost of Revenue figures came in at $108.7 million (Q2 2026), $116.7 million (Q1 2026), and $118.0 million (Q4 2025), per Business Quant data.